01 69ANI PHARMS
02 9MALLINCKRODT IRELAND
01 911752199
02 2311975047
03 4612102662
01 78Blank
01 78Blank
01 92041-02-25
02 692043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3916
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3917
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3917
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3918
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3918
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3919
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3919
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3920
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3920
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
Patent Expiration Date : 2043-10-27
US Patent Number : 12102662
Drug Substance Claim :
Drug Product Claim :
Application Number : 8975
Patent Use Code : U-3921
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2043-10-27
